Delivery Order SPE2DB22D2206-SPE2DB25FHT94

Award Date 7/7/25
Potential Completion Date 7/8/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of hydromorphone, a pain medication. The contract has a ceiling value of $2,617.96 and a performance period ending on May 28, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Hydromorphone 1 mg/ml, a pain management medication, with a ceiling value of $2,705.56 and a period of performance through May 6, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,248.83, is for the supply of hydromorphone 2 mg/ml in cartridges. The contract is a firm fixed-price delivery order with a completion date of September 10, 2024. Amerisourcebergen, through its Corporate Office Division, has been a significant supplier of pharmaceutical products and medical...
This federal contract award, valued at $1,583.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of HYDROMORPHONE 1 MG/ML CARPUJCTML, a pharmaceutical product. The contract has an ultimate completion date of December 10, 2024 and a Firm Fixed Price pricing type. The contract was not subject to any set-aside requirements, indicating open...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of hydromorphone 0.5 mg/0.5 ml 0.5 ml medication. The contract, valued at $1,001.01, has a period of performance through May 8, 2025. Amerisourcebergen Drug Corp, a for-profit organization headquartered in Conshohocken, Pennsylvania, is the prime contractor. This award is not set-aside and is part of a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Hydromorphone 50 mg/5 ml vial, a pain management medication, with a total ceiling value of $1,037.22. The contract is a firm fixed price, non-set-aside award with a performance period extending until May 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $2,677.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564847126 - HYDROMORPHONE 1 MG/ML CARPUJCTML, a pharmaceutical product, with a completion date of June 10, 2024. The award is a Firm Fixed Price delivery order contract, which indicates that AmerisourceBergen will provide a fixed quantity of the specified...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,373.36 firm fixed price contract is for the delivery of 12mg hydromorphone hydrochloride extended-release tablets to support military healthcare programs. The award has a period of performance through November 20, 2024. This contract is not designated as...
This federal contract award, valued at $1,282.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hydromorphone 2 mg/ml, a pain management medication, with a performance period through April 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $5,324.32 and is for the delivery of hydromorphone hydrochloride extended-release 8 mg tablets. The contract is not set aside and was awarded on July 9, 2025, with a performance period through July 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FHT94
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of hydromorphone 1 mg/ml carpujctml. The contract has a firm fixed price of $1,998.74 and a period of performance through July 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This specific delivery order is not designated as a set-aside contract.

Generated 10/6/25, 12:47 PM